Mount Sinai Researchers have discovered that dupilumab (Dupixent, Sanofi) may represent a therapeutic option for keloids as during a recent study a patient using the drug for severe disease experienced a great reduction in the size of their keloids. Recently reported...
A recent study sponsored by Icahn School of Medicine, Mount Sinai and the American Heart Association found that both individual and group-based heart disease prevention management courses were more beneficial for reduced patient risk than standard lifestyle...
Rice University researchers developed a new cancer therapy using nanoparticles to heat and destroy tumors and revealed encouraging results in a clinical trial. Background Published in the journal Proceedings of the National Academy of Sciences, the study revealed that...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
